Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

A new method was developed to make finasteride for treating hair loss.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Finasteride, a medication, is being re-evaluated for its effects and uses.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Tamsulosin can worsen sleep apnea in some patients.

Retinoids are effective for acne but can cause serious side effects.

Sodium valproate can cause serious high blood pressure in children.

These medications for BPH have known risks and may have new side effects.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

These medications for BPH have known risks and may have new side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Terazosin and finasteride together cause no major issues.